DesethylKBT-3022是新型抗血小板药物KBT-3022的主要活性代谢物。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Desethyl KBT-3022 is the main active metabolite of the new antiplatelet agent, KBT-3022.
Pretreatment with desethyl KBT-3022 0.1, 0.3 and 1 mg/kg, i.v. prolongs the time required to achieve thrombotic occlusion in the femoral artery and inhibits collagen-induced platelet aggregation in whole blood ex vivo, each in a dose-dependent manner. Desethyl KBT-3022 inhibits the thrombin-induced aggregation of washed platelets in a concentration-dependent manner 1-40 μM[1].
[1]. Shimazawa M, et al. Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022. Eur J Pharmacol. 1997 Jun 11;328(2-3):183-9.
LX1606 Hippurate (Telotristat etiprate)
¥580.00 ¥725.00
没有评价数据